Master's pharmacology asks you to pick an antibiotic for a patient. Doctoral pharmacology asks why your clinic keeps reaching for the wrong one and what you intend to do about that. This stage moves from the single prescription to the prescribing pattern: reading a local antibiogram, choosing durations that trials support rather than durations that habit produced, questioning recorded allergies, and designing a measurable change. Bring a metric, because a stewardship argument without one cannot be graded as practice scholarship. Your section may attach this material to a discussion, to a submitted paper, or to both, and only the syllabus can tell you which.
This manual sits at week six by our own reckoning and by nothing else. With no syllabus published outside the classroom and course guides gated behind a student login, the real order remains unknown to us, so treat the number as a teaching convenience and let the schedule your instructor posted govern what you actually write this week.
How a stewardship argument is graded
The distinguishing row asks whether you used local data. National guidance sets the frame, but the antibiogram from your own facility decides whether the recommended first line agent still covers the organisms your patients grow, and doctoral work is expected to reach for that document.
A second row grades duration. Trial evidence across several common infections has moved toward shorter courses, and a paper that prescribes the length it remembers from training rather than the length the evidence supports loses the row that grades currency.
The last row is measurement. Name what you would count, over what period, against what baseline, and what change would count as success. A stewardship proposal with no denominator is an opinion, and doctoral rubrics score it that way.
Six moves in building a stewardship case
How our writers turn a prescribing problem into a proposal a committee could actually approve.
-
Describe the prescribing pattern with numbers
State what is being prescribed, how often, and for which presentations. A pattern quantified from clinic data is the foundation of the argument, and an impression of overuse is not.
-
Open the local resistance report
Susceptibility percentages differ between institutions and between years. Quote the figures your setting publishes, and say plainly whether the guideline preferred agent still clears the threshold that makes empiric use reasonable.
-
Interrogate the allergy record
A large majority of recorded penicillin allergies do not survive proper evaluation, and the label pushes prescribing toward broader and less effective alternatives. Include an assessment pathway rather than accepting the record as fact.
-
Set duration from the trials, not from tradition
For several common infections, shorter courses have matched longer ones on cure while producing less collateral harm. Cite the evidence for the length you choose and say what would justify extending it.
-
Design the de-escalation step
Empiric therapy is a starting position. Write when cultures will be reviewed, who reviews them, and what narrowing will follow, because the review that never happens is where stewardship programs quietly fail.
-
Choose a metric and a baseline
Days of therapy per patient encounter, proportion of first line prescribing, or percentage of courses stopped on schedule. Pick one, state the current value, name the target and the review interval, and say who reports it.
The shape of a stewardship proposal
A frame our bench uses for program level pharmacology writing, which your rubric should reshape wherever it distributes points differently.
| Section | What goes inside | What the row is buying |
|---|---|---|
| Problem statement | The prescribing behavior, quantified, with the population it affects. | A number attached to the problem and a source for that number. |
| Local evidence | Antibiogram figures, formulary constraints, and setting specific patterns. | Institutional data used, with the susceptibility threshold interpreted. |
| Recommended pathway | First line agent, dose, duration, and the conditions that change the choice. | A pathway short enough to follow and specific enough to audit. |
| Allergy and exception handling | Assessment of recorded allergies and the alternatives when a reaction is real. | An evaluation route rather than automatic escalation to broader therapy. |
| Implementation | Who changes what, the tools involved, and the education or order set required. | Named roles and concrete mechanisms rather than an appeal to awareness. |
| Measurement plan | Metric, baseline, target, interval, and the person reporting the result. | A countable outcome with a denominator and a review date. |
Annotated sample excerpt: first line prescribing in an outpatient clinic
This passage shows local data doing the work that a general guideline citation cannot do by itself.
The 2025 antibiogram for this outpatient network reports 82 percent susceptibility among urinary Escherichia coli isolates to trimethoprim with sulfamethoxazole, which sits above the commonly cited threshold for empiric use, so the pathway retains it as a first line option alongside nitrofurantoin rather than defaulting to a fluoroquinolone.1 Chart review of 212 consecutive uncomplicated cases found fluoroquinolone prescribing in 38 percent of encounters despite regulatory warnings about tendon, nerve and aortic harm reserving those agents for situations without alternatives, and that proportion becomes the baseline metric for the proposal.2 The intervention combines a default order set, a monthly clinician level report and a five minute case discussion at staff meeting, with success defined in advance as first line prescribing above 80 percent sustained across two consecutive quarters.3
- 1Local susceptibility is quoted with its year and then interpreted against a decision threshold, which is what separates stewardship writing from guideline summary.
- 2The problem is measured before the fix is proposed, giving the later metric a baseline that a reviewer can check.
- 3Success is defined numerically and with a time horizon, so the proposal could be audited by somebody who was never in the room.
Forward the stewardship prompt with whatever grading grid your section posted; the opening premium sample is free, local data argument and measurement plan already assembled.
Five failures in a stewardship paper
- National guidance quoted with no local data. Susceptibility varies by setting and by year, and a recommendation that never meets local numbers cannot claim to fit the clinic.
- Durations carried over from training. Several infections now have evidence supporting shorter treatment, and defaulting to the familiar length loses the currency row.
- Recorded allergies accepted without challenge. Most penicillin allergy labels do not survive evaluation, and leaving them unexamined drives avoidable use of broader agents.
- De-escalation described but never assigned. A review with no named owner and no scheduled time does not happen, and the paper is proposing an outcome without a mechanism.
- No metric, no baseline, no target. Without a countable measure the proposal cannot be evaluated, which places it below the standard doctoral rows are written to.
Before the proposal goes in
- The prescribing problem is stated as a proportion with a source
- Local susceptibility figures appear with their year
- Chosen durations are tied to trial evidence
- An allergy assessment route is included rather than assumed
- De-escalation names an owner and a time
- The metric has a baseline, a target and a review interval
Stewardship assignment on the calendar?
Give us the prompt, any local data your instructor supplied and the rubric from the classroom. A premium original built around a measurable intervention lands in 24 to 48 hours with the resistance argument done properly, and we rewrite at no cost until the rows are covered.